Evidence map›Paper›PMID 40959683›Full record

ArticlePostepy psychiatrii neurologii2025

Psychedelic use in Poland: prevalence, correlates and social attitudes.

Paweł Holas, Justyna Kamińska

Abstract read
In one paragraph

Article in Postepy psychiatrii neurologii, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paweł HolasDepartment of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Warsaw, Poland.ORCID https://orcid.org/0000-0002-4210-3396
Justyna KamińskaDepartment of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Recent years have witnessed a renewed interest in research exploring the therapeutic potential of classic psychedelics, such as psilocybin and lysergic acid diethylamide (LSD) in the treatment of mental disorders. However, our knowledge of the epidemiology of their use, factors associated with their recreational consumption, and attitudes toward these substances remains limited. Methods: A representative sample of Polish adults ( Results: Between 4% and 8% of Polish adults, equivalent to approximately 2 million people, have experimented with psychedelic substances at least once in their lives. Men were more likely to use psychedelics than women, with the largest group of users being individuals aged 25-34, primarily residing in urban areas. Curiosity emerged as the most common motivation for use, and home was typically reported as the context. The psychedelic experience was often described as a mixture of pleasant and unpleasant sensations. A substantial proportion of participants expressed indifferent or negative attitudes towards both PAT and psychedelics. However, prior psychedelic use, younger age, and a history of lifetime meditation practice were associated with more positive attitudes. Conclusions: Approximately 6% of Polish adults, mostly young men living in urban areas, reported using classic psychedelics, particularly LSD and psilocybin mushrooms. Further research and educational efforts are needed to support the scientific exploration of PAT, and to help shift public perceptions of its therapeutic potential.

Indexed as

attitudes toward psychedelicsepidemiologypsychedelic-assisted therapypsychedelicssociodemographic factors

Identifiers

PMID40959683
PMCPMC12435566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.